Ultragenyx Pharmaceutical RARE
NASDAQ RARE
$15.22 +0.47 (+3.19%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ultragenyx Pharmaceutical (RARE) Shares Outstanding (Diluted) (2017 - 2026)

Updated

Ultragenyx Pharmaceutical (RARE) reported Shares Outstanding (Diluted) of 101.9 million for Q2 2026, up 3.5% from 98.46 million a year earlier and up 1.3% from the prior quarter.

Analysis

Ultragenyx Pharmaceutical (RARE) Shares Outstanding (Diluted) (2017 - 2026) Analysis & Trends

For FY2025, Ultragenyx Pharmaceutical posted Shares Outstanding (Diluted) of 98.6 million, up 8.9% from FY2024.

  • Shares Outstanding (Diluted) has increased for eight consecutive years, with a five-year compound annual growth rate of 10.1% (FY2020 to FY2025).
  • By year, Shares Outstanding (Diluted) came in at 90.54 million in FY2024 (+23.1%), 73.54 million in FY2023 (+5.2%), 69.91 million in FY2022 (+3.1%) and 67.8 million in FY2021 (+11.4%).
  • The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Diluted) in data going back to Q1 2017.
  • Year over year, Shares Outstanding (Diluted) has now increased in each of the last 25 quarters, with growth averaging 13.2% over the last eight quarters.
  • The year-over-year growth in Shares Outstanding (Diluted) has ranged between 1.2% (Q1 2023) and 33.3% (Q3 2024) over the last five years.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 100.6 million (Q1 2026), 98.6 million (Q4 2025) and 99.77 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 893.70 Mn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.44 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.77 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.47 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.56 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 544.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.24 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 5.70 Bn
10 Ultragenyx Pharmaceutical 1.50 Bn -302.56 Mn 180.00 Mn 101.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 101.90 Mn
Mar 31, 2026 100.60 Mn
Dec 31, 2025 98.60 Mn
Sep 30, 2025 99.77 Mn
Jun 30, 2025 98.46 Mn
Mar 31, 2025 96.29 Mn
Dec 31, 2024 90.54 Mn
Sep 30, 2024 95.49 Mn
Jun 30, 2024 86.58 Mn
Mar 31, 2024 84.29 Mn
Dec 31, 2023 73.54 Mn
Sep 30, 2023 71.66 Mn
Jun 30, 2023 70.90 Mn
Mar 31, 2023 70.37 Mn
Dec 31, 2022 69.91 Mn
Sep 30, 2022 70.05 Mn
Jun 30, 2022 69.93 Mn
Mar 31, 2022 69.52 Mn
Dec 31, 2021 67.80 Mn
Sep 30, 2021 67.88 Mn
API Access

Ultragenyx Pharmaceutical Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=RARE&period=max&api_key=YOUR_API_KEY